Estrogen-induced tumorigenesis in the Copenhagen rat: Disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas

Cancer Letters

Volumn 124, Issue 1, 1998, Pages 95-103

  Spady, Thomas J ^a,b   Harvell, Djuana M E ^a,b   Snyder, Mary C ^a   Pennington, Karen L ^a   McComb, Rodney D ^a,b   Shull, James D ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

17 estradiol; Aci rat; Copenhagen rat; Diethylstilbestrol; Hyperprolactinemia; Prolactin

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARCINOGENS; DIETHYLSTILBESTROL; DISEASE SUSCEPTIBILITY; ESTRADIOL; FEMALE; HYPERPROLACTINEMIA; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; PITUITARY NEOPLASMS; PROLACTINOMA; RATS; RATS, INBRED STRAINS;

ANIMALIA;

EID: 0032512612     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00455-2     Document Type: Article

References (24)

1. Blankenstein M.A., Broerse J.J., van Zwieten M.J., van cer Molen H.J. Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17β Breast Cancer Res. Treat. 4:1984;137-141.
2. Clifton K.H. Problems in experimental tumorigenesis of the pituitary gland, gonads, adrenal cortices and mammary glands: a review. Cancer Res. 19:1959;2-22.
3. Cutts J.H., Noble R.L. Estrone-induced mammary tumors in the rat I. Induction and behavior of tumors. Cancer Res. 24:1964;1116-1123.
4. Dunning W.F., Curtis M.R. The incidence of diethylstilbestrol-induced cancer in reciprocal F1 hybrids obtained from crosses between rats of inbred lines that are susceptible and resistant to the induction of mammary cancer by this agent. Cancer Res. 12:1952;702-706.
5. Dunning W.F., Curtis M.R., Madsen M.E. Diethylstilbestrol-induced mammary gland and bladder cancer in reciprocal F1 hybrids between two inbred lines of rats. Acta-Unio Internationalis Contra Cancrum. 7:1951;238-244.
6. Dunning W.F., Curtis M.R., Segaloff A. Strain differences in response to diethylstilbestrol and the induction of mammary gland and bladder cancer in the rat. Cancer Res. 7:1947;511-521.
7. M.F.W. Festing, Inbred strains, in: D.E.J. Baker (Ed.), The Laboratory Rat, Academic Press, New York, 1979, pp. 55-72.
8. Furth J., Clifton K.H., Gadsden E.L., Buffett R.F. Dependent and autonomous mammotropic pituitary tumors in rats; their somatotropic features. Cancer Res. 16:1956;608-616.
9. Gersten B.E., Baker B.L. Local action of intrahypophyseal implants of estrogen as revealed by staining with peroxidase-labeled antibody. Am. J. Anat. 128:1970;1-19.
10. Gooren L.J.G., Assies J., Asscheman H., de Slegte R., van Kessel H. Estrogen-induced prolactinoma in a man. J. Clin. Endocrinol. Metab. 66:1988;444-446.
11. Hus L.-C., Kennan W.S., Shepel L.A., Jacob H.J., Szpirer C., Szpirer J., Lander E.S., Gould M.N. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res. 54:1994;2765-2770.
12. Isaacs J.T. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res. 46:1986;3958-3963.
13. Isaacs J.T. Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis. Cancer Res. 48:1988;2204-2213.
14. Kovacs K., Stefaneanu L., Ezzat S., Smyth H.S. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration: a morphologic study. Arch. Pathol. Lab. Med. 118:1994;562-565.
15. Lloyd R.V. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. Am. J. Pathol. 113:1983;198-206.
16. McEuen C.S. Occurrence of cancer in rats treated with oestrone. Am. J. Cancer. 34:1938;184-195.
17. Noble R.L., Cutts J.H. Mammary tumors of the rat: a review. Cancer Res. 19:1959;1125-1139.
18. Panteon E., Loumaye E., Maes M., Malvaux P. Occurrence of prolactinoma after estrogen treatment in a girl with constitutional tall stature. J. Pediatr. 113:1988;337-339.
19. Scully K.M., Gleiberman A.S., Lindzey J., Lubahn D.B., Korach K.S., Rosenfeld M.G. Role of estrogen receptor-α in the anterior pituitary gland. Mol. Endocrinol. 11:1997;674-681.
20. Shull J.D., Gorski J. The hormonal regulation of prolactin gene expression: an examination of mechanisms controlling prolactin synthesis and the possible relationship of estrogen to these mechanisms. Vitamins Hormones. 43:1986;197-249.
21. Shull J.D., Spady T.J., Snyder M.C., Johansson S.L., Pennington K.L. Ovary intact, but not ovariectomized female ACI rats treated with 17β-estradiol rapidly develop mammary carcinoma. Carcinogenesis. 18:1997;1595-1601.
22. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331:1994;1056-1061.
23. Stone J.P., Holtzman S., Shellabarger C.J. Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Sprague-Dawley rats. Cancer Res. 39:1979;773-778.
24. Wiklund J., Rutledge J., Gorski J. A genetic model for the inheritance of pituitary tumor susceptibility in F344 rats. Endocrinology. 109:1981;1708-1714.